Participating organizations

Get to know our host institutions and associated partners!

See more

WHAT IS INTERCEPT-MDS?

EXPLORING CELL-TO-CELL HETEROGENEITY AND EXPLOITING EPIGENETIC REGULATION FOR THE INTERCEPTION OF MYELOID DISEASE CELLS

INTERCEPT-MDS is an Innovative Training Network of 18 public and private partners from 7 countries.

 

 

Through a multidisciplinary and multisectoral approach, our aim is to train Europe’s first experts in the novel field of disease interception: treating a disease before it fully develops by removing altered cells.

NEWS

01.01.2021
Official starting date of the H2020 funded INTERCEPT-MDS Innovative Training Network

TWITTER